Navigation Links
Australian Snake Venom Can Arrest Bleeding During Surgery And Trauma

It has been found that the venom of Australian snakes can rapidly arrest bleeding during major trauma and vascular surgery.The finding could eventually pave way for // development of the next generation of therapeutic drugs for humans.

Taipan venom has been found to contain high amounts of a blood-clotting protein, referred to as factor X. The gene responsible for the production of factor X has been identified by Liam St Pierre, a researcher from Queensland University of Technology.

The main focus of the study was in deciphering the genetic constitution of Taipan's venom. Liam was involved in the analysis of venom of 8 of Australia's deadliest land snakes (tiger snake, Stephens banded snake, the rough-scaled snake, the mulga, the red bellied black, the common brown and coastal Taipan) regarding their use in therapeutics. Eventually, he landed up identifying genetic code responsible for production of pro-coagulant, Factor X.

'Australian snakes literally have a two-pronged attack when they bite their prey. Firstly, venom injection causes massive blood clots instantaneously followed by paralysis as a result of neurotoxins which eventually immobilize and kill the victim,' said Dr St Pierre.

Snakes over the years have developed the ability to produce a faster acting and stable form of Factor X in their venom. This is the only alternative source for generation of Factor X, excluding the mammalian livers. The mass delivery of Factor X results in inactivation of specific human systems, resulting in death. QrxPharma, a pharmaceutical company is currently considering the initiation of clinical trials of the potential 'life-saving drug'.

The study is the first extensive study conducted on genes responsible for production of snake's toxins. Factor X has the potential to be exploited in a number of novel drug therapies. Further analysis of the different kinds of snake venom could provide for new components that could b
'"/>




Page: 1 2

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
3. Australian Company Gets $10 million For Developing Skin Cancer Gel
4. Australian Health funds stand accused
5. Australian Court Finds Man Guilty of Spreading HIV/AIDS
6. Australian Scientists Develop Novel Drug To Combat Inflammatory Diseases
7. Sale Of Bird Flu Vaccine to US Planned: Australian Firm
8. Hepatitis C Could Infect 800,000 Australians By 2020
9. Obesity Cost More Than The Australian Health Budget
10. Fat Virus, Ad-36 Blamed For Obesity Epidemic In Australians
11. Its High Time the Australian Government Takes Steps against Diabetes
Post Your Comments:
(Date:7/25/2008)...stCall/ -- Thoratec,Corporation (Nasdaq: THOR ) a...ry support therapies to save, support and restore ...t its operating results for the second,quarter and... 31., The company will hold a conference call to ...ties to all interested parties at 1:30 p.m.,Pacif...
(Date:7/25/2008)...or obese is not only a personal issue that affects...at impacts other people in society. A new study in...at the extra Medicare cost associated with overwei...cial burden on tax payers, costing up to hundreds ...edicare population. , The article,s findings sh...
(Date:7/25/2008)...y.com announces the,availability of Trade Alerts o...ll of the daily trading notes for free by visiting...ts include: DUSA Pharmaceuticals Inc. (Nasdaq: DU...BRK ), NovaMed Inc. (Nasdaq:,NOVA), Adolor Corp. (...and,Abaxis Inc. (Nasdaq: ABAX )., Join investor ...
(Date:7/25/2008)...ense and Federal Agencies in, the execution of Op...s a, four-day, multi-agency collaborative traini...cal agencies with large and complex incident respo...d-hoc, secure mobile communications infrastructu... Va., July 25 /PRNewswire/ -- Dataline LLC is plea...
Breaking Medicine News(10 mins):Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3
...to that apple or lentils, for a new study has foun...lowly once they have been consumed helps dieters l...ood sugar levels. Foods that release sugars rapid... index - those that release it slowly have a low g...
...mours once again when she was pictured with baby b...re of John Travolta starrer Hairspray dressed in a... her bump, reports the Daily Mail. Holmes sparked...nd hubby Tom Cruise were expecting their second ch...
...t a government-run district hospital in Chhattisga...grawal told the state assembly Tuesday . Amid prot...mbers about the lack of basic medical facilities a...spital in Raigarh district had reported 424 deaths...
...mulation models suggests that the lifetime risk of... computed tomography (CT scan) coronary angiograph...nd younger patients. Coronary artery disease (CAD...and women in the United States, accounting for 1 i...
Other Medicine News:Health News:Apples and Lentils Could Help You to Shed Off Those Extra Pounds! 2Health News:CT Scan Radiations may Lead to Cancer 2
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ ...nt of Justice:, Chairman Conyers, Ranking Member ... the opportunity to testify today., Since I appea... have,become even better acquainted with the talen...artment and with the work they do, and I have come...
(Date:7/23/2008)... SEATTLE, July 23 /- D...ed that it expects the Independent Data,Monitoring...terim analysis,of overall survival relating to the...ate AdenoCarcinoma Treatment, also known as D9902B...OVENGE is the Company,s investigational,active cel...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin M...oring solutions for more than 20 years, has entere... technology to measure,regional oxygen saturation....gy is the continuous monitoring of the regional bl..., Early testing data and outcomes from an ongoing...
(Date:7/22/2008)... - State-of-the-Art PET Study Confirms Tyrima Ex... Properties - - Results Support Initiat...GLE PARK, N.C., July 22 /- CeNeRx Bio...and commercializing innovative,treatments for dise...d,plans to advance its lead candidate Tyrima(TM) i...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Bottom trawling impacts clearly visible from space 2221 1Bottom trawling impacts clearly visible from space 2221 2Bottom trawling impacts clearly visible from space 2221 3Dr Welsh Self Test Diagnoses Glaucoma the Leading Cause of Preventable Blindness 12056 1Dr Welsh Self Test Diagnoses Glaucoma the Leading Cause of Preventable Blindness 12056 2DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 1DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 2Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 1Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 2
...es Positive Data in Nonclinical (IND) In- Vitro,St...ay 3, 2007 (PRIME NEWSWIRE) -- Samaritan,Pharmaceu...drugs,is pleased to announce positive results wer...ical testing of Caprospinol (SP-233),with well re...esearch results are imperfect predictors,of clinic...
...., May 02, 2007 /PRNewswire/ -- Ceregene, Inc.,tod...trial of,CERE-110, a gene therapy product designed...tment of Alzheimer,s disease. After one,year of fo...ived,CERE-110 in the trial indicate that a single ...and an interim analysis suggested that,the therapy...
Other Medicine Technology:Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 2Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 3Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 4
Curved shafts and tips with 6 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches.
Curved shafts and tips with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in closed position with polished finish. Overall length 4.3 inches.
5 mm tying platform. Round knurled handle with dull finish. Curved shafts. Overall length 3.9 inches.
Slightly curved 10 mm jaws and serrated cross action handle with polished finish. Overall length 4.6 inches.
Medicine Products: